Russell K Pachynski, MD

Prostate specific antigen doubling time (PSADT) in patients with hormone refractory prostate cancer (HRPC) undergoing docetaxel chemotherapy as a predictor of overall survival.

Pachynski RK, King C, Srinivas S. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings. 2007; 25 (18s): 15556